Literature DB >> 25917798

Group B meningococcal vaccine science and policy.

Simon B Drysdale1, Andrew J Pollard2.   

Abstract

Capsular group B Neisseria meningitidis is one of the leading causes of death in developed countries. A new vaccine (4CMenB) has recently been developed which was found to have an acceptable safety profile in clinical studies and to be immunogenic. This review examines the evidence supporting the licensure of the 4CMenB vaccine and discusses recommendations for its use.
Copyright © 2015 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Capsular group B Neisseria meningitidis; Capsular group C Neisseria meningitidis; Children; Immunogenicity; Infant; Reactogenicity; Vaccine

Mesh：

Substances：

Year:  2015        PMID： 25917798     DOI： 10.1016/j.jinf.2015.04.021

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


  4 in total

1.  Persistence of immunity after vaccination with a capsular group B meningococcal vaccine in 3 different toddler schedules.

Authors:  Manish Sadarangani; Tim Sell; Mildred A Iro; Matthew D Snape; Merryn Voysey; Adam Finn; Paul T Heath; Gianni Bona; Susanna Esposito; Javier Diez-Domingo; Roman Prymula; Adefowope Odueyungbo; Daniela Toneatto; Andrew J Pollard
Journal:  CMAJ       Date:  2017-10-16       Impact factor: 8.262

Review 2.  Meningococcal B vaccination: real-world experience and future perspectives.

Authors:  Parvanè Kuhdari; Armando Stefanati; Silvia Lupi; Nicoletta Valente; Giovanni Gabutti
Journal:  Pathog Glob Health       Date:  2016-06-16       Impact factor: 2.894

3.  Need for Optimisation of Immunisation Strategies Targeting Invasive Meningococcal Disease in the Netherlands.

Authors:  Josefien Cornelie Minthe Bousema; Joost Ruitenberg
Journal:  Int J Health Policy Manag       Date:  2015-09-13

4.  Paediatric Virology and respiratory syncytial virus: An interview with Honorary Senior Lecturer in Paediatric Infectious Diseases Dr Simon B. Drysdale (St. George's, University of London, UK).

Authors:  Ioannis N Mammas; Demetrios A Spandidos
Journal:  Exp Ther Med       Date:  2019-08-28       Impact factor: 2.447
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.